World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
81
Citations
35721
World Ranking
3799
National Ranking
1881

Robert A. Copeland publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Robert A. Copeland sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 328 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Robert A. Copeland D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Robert A. Copeland sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 81 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2016 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Robert A. Copeland is affiliated with Accent Therapeutics in the United States. Their research spans multiple fields including Medicine and Environmental Science, with a focus on subfields such as Pulmonary and Respiratory Medicine, Health, Toxicology and Mutagenesis, and Cardiology and Cardiovascular Medicine.

The scientist's work addresses several main topics covering Infection Control and Ventilation, Climate Change and Health Impacts, and Cardiovascular Effects of Exercise.

Robert A. Copeland has contributed to the following recent publication:

  • End-to-end SARS-CoV-2 transmission risks in sport: Current evidence and practical recommendations, 2021, South African Journal of Sports Medicine

Frequent co-authors collaborating with Robert A. Copeland include:

  • Ben Jones
  • Gemma Phillips
  • Federica Valeriani
  • Thomas Edwards
  • Emily R. Adams

Their contributions have appeared primarily in the South African Journal of Sports Medicine.

Robert A. Copeland was recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 2016.

Best Publications

  • IDENTIFICATION OF A NOVEL INHIBITOR OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE

    Margaret F. Favata;Kurumi Y. Horiuchi;Elizabeth J. Manos;Andrea J. Daulerio

  • Enzymes : a practical introduction to structure, mechanism, and data analysis

    Robert Allen Copeland

  • Drug–target residence time and its implications for lead optimization

    Robert A. Copeland;David L. Pompliano;Thomas D. Meek

  • Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists

    Robert Allen Copeland

  • Evaluation of enzyme inhibitors in drug discovery

    Robert Allen Copeland

  • Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor

    Scott R. Daigle;Edward J. Olhava;Carly A. Therkelsen;Christina R. Majer

  • The promise and peril of chemical probes.

    Cheryl H. Arrowsmith;James E. Audia;Christopher Austin;Jonathan Baell

  • A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells

    Sarah K Knutson;Tim J Wigle;Natalie M Warholic;Christopher J Sneeringer

  • Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins.

    M. D. Tortorella;T. C. Burn;M. A. Pratta;I. Abbaszade

  • Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2

    Sarah K. Knutson;Natalie M. Warholic;Tim J. Wigle;Christine R. Klaus

  • Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas

    Christopher J. Sneeringer;Margaret Porter Scott;Kevin W. Kuntz;Sarah K. Knutson

  • Potent inhibition of DOT1L as treatment of MLL-fusion leukemia.

    Scott R. Daigle;Edward J. Olhava;Carly A. Therkelsen;Aravind Basavapathruni

  • The drug-target residence time model: a 10-year retrospective

    Robert A. Copeland

  • Residence time of receptor-ligand complexes and its effect on biological function.

    Peter J. Tummino;Robert A. Copeland

  • Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family.

    Ilgar Abbaszade;Rui-Qin Liu;Fude Yang;Stuart A. Rosenfeld

  • Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma

    Sarah K. Knutson;Satoshi Kawano;Yukinori Minoshima;Natalie M. Warholic

  • Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study

    Antoine Italiano;Jean-Charles Soria;Maud Toulmonde;Jean-Marie Michot

  • Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase

    Robert A. Copeland;Jean M. Williams;John Giannaras;Sherrill Nurnberg

  • MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products.

    John V. Duncia;Joseph B. Santella;C.Anne Higley;William J. Pitts

  • A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models

    Elayne Chan-Penebre;Kristy G Kuplast;Christina R Majer;P Ann Boriack-Sjodin

Frequent Co-Authors

J. Joshua Smith
J. Joshua Smith Memorial Sloan Kettering Cancer Center
James M. Trzaskos
James M. Trzaskos Bristol-Myers Squibb (Germany)
Thomas G. Spiro
Thomas G. Spiro University of Washington
William F. DeGrado
William F. DeGrado University of California, San Francisco
Giulio Superti-Furga
Giulio Superti-Furga Medical University of Vienna
Stefan Knapp
Stefan Knapp Goethe University Frankfurt
Scott A. Armstrong
Scott A. Armstrong Harvard University
Matthieu Schapira
Matthieu Schapira University of Toronto
Cheryl H. Arrowsmith
Cheryl H. Arrowsmith Structural Genomics Consortium

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in Biology or Biochemistry, a range of online degrees can expand your career opportunities in healthcare, research, and management. Many students transition from these fields into healthcare leadership by enrolling in top cahme-accredited mha programs. These programs focus on high-level skills needed to manage hospitals, labs, and health organizations.

For those interested in advanced nursing roles, the msn to dnp online no clinicals pathway is an option. These flexible online programs allow qualified nurses to earn their DNP without in-person clinicals, making it easier to balance work and study.

If you’re aiming for academic or executive roles, consider a phd in healthcare management. This degree prepares you to lead research projects, direct policy, or teach at the university level.

Finally, students fascinated by drug development or pharmacy can explore the best online pharmacy school options. A doctorate in pharmacy opens doors to clinical, research, and industry leadership roles.

Best Scientists Citing Robert A. Copeland

Trending Scientists

Recently Published Articles